A research consortium led by Principal Researcher An Jinung of South Korea's DGIST Industrial AX Innovation Institute and Professor Jeon Seong-chan of the Gwangju Institute of Science and Technology has developed the first artificial intelligence system capable of objectively quantifying pain intensity. The methodology was detailed in IEEE Transactions on Neural Systems and Rehabilitation Engineering in 2026. The technology analyzes electroencephalogram signals elicited by controlled thermal stimuli to replace traditional subjective assessment protocols. Conventional pain evaluation depends on the Visual Analog Scale, which requires patient self-reporting. This reliance creates inconsistent results due to inherent variations in pain perception and proves ineffective for non-verbal populations, including sedated individuals, children, and elderly patients. To resolve this, the team engineered a dual AI architecture that cross-validates prediction outputs and selectively trains exclusively on high-confidence data. This approach effectively filters out the noise and bias associated with subjective labeling. Validation using electroencephalogram recordings from forty-one participants demonstrated that the novel model significantly outperformed conventional algorithms in pain intensity classification. The system also maintained stable predictive accuracy in novel stimulus environments where it had not been explicitly trained. Neurophysiological mapping further established that delta wave activity in the F7 and F8 regions of the anterior temporal lobes correlates directly with pain levels, creating a reproducible neurophysiological foundation for brain-based digital biomarkers. Researchers note that circumventing subjective self-reporting represents a pivotal advancement for electroencephalogram-driven pain analysis. First author Jeong Ui-jin identified immediate clinical utility in pre- and post-operative monitoring, chronic pain management, and intensive care unit assessments. The development team intends to integrate additional bio-signals to transition the prototype into a universal clinical pain platform. Subsequent research will prioritize adapting the system for real-time brain-computer interface monitoring, establishing a standardized framework for objective pain evaluation across healthcare settings.